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Abstract: Trophoblasts are the first cell type to be specified during embryogenesis, and they are
essential for placental morphogenesis and function. Trophoblast stem (TS) cells are the progenitor
cells for all trophoblast lineages; control of TS cell differentiation into distinct trophoblast subtypes
is not well understood. Mice lacking the transcription factor OVO-like 2 (OVOL2) fail to produce a
functioning placenta, and die around embryonic day 10.5, suggesting that OVOL2 may be critical for
trophoblast development. Therefore, our objective was to determine the role of OVOL2 in mouse
TS cell fate. We found that OVOL2 was highly expressed in mouse placenta and differentiating
TS cells. Placentas and TS cells lacking OVOL2 showed poor trophoblast differentiation potential,
including increased expression of stem-state associated genes (Eomes, Esrrb, Id2) and decreased levels
of differentiation-associated transcripts (Gcm1, Tpbpa, Prl3b1, Syna). Ectopic OVOL2 expression in
TS cells elicited precocious differentiation. OVOL2 bound proximate to the gene encoding inhibitor
of differentiation 2 (ID2), a dominant negative helix-loop-helix protein, and directly repressed its
activity. Overexpression of ID2 was sufficient to reinforce the TS cell stem state. Our findings reveal a
critical role of OVOL2 as a regulator of TS cell differentiation and placental development, in-part by
coordinating repression of ID2.
Keywords: embryogenesis; blastocyst; transcriptional repression; trophoblast stem cells; trophoblast
differentiation; placenta; OVO-like 2

1. Introduction
Trophoblast is the first cell type to become specified during early embryogenesis. These cells
ultimately form the epithelial portion of the placenta and perform crucial functions that support fetal
growth and development. The precursors for all distinct trophoblast lineages are trophoblast stem (TS)
cells, which can be derived from the early embryo and are a powerful tool for determining cell fate
decisions in extraembryonic lineages. Precise spatial and temporal control of TS cell differentiation
is fundamental for normal placental morphogenesis and function [1], but the regulation of TS cell
differentiation is poorly understood.
Mouse models have been instrumental in advancing our understanding of TS cell development and
providing insight into the morphology and function of the placenta [2,3]. The regulation of mouse TS
cell maintenance and differentiation has been extensively studied, since culture conditions that facilitate
long-term TS cell culture and differentiation in this species have been known for several decades,
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whereas culture conditions for human TS cells have only recently been described [4,5]. Additionally,
our understanding of the complexities of TS cell development and placental organization has greatly
benefitted from mouse mutagenesis, where placentation defects are implicated in a considerable
proportion of mouse mutants exhibiting embryonic lethality [6]. Many genes essential for rodent
trophoblast development have subsequently been shown to have critical roles in human placentation,
or are dysregulated during pregnancy pathologies, demonstrating the value of rodent models for
enhancing our understanding of placental development.
During mouse TS cell differentiation, a subset of genes associated with the stem-state are repressed,
including caudal box homeodomain 2 (Cdx2), estrogen related receptor beta (Esrrb), eomesodermin
(Eomes), and inhibitor of DNA binding 2 (also called inhibitor of differentiation 2, Id2). Additionally,
expression of genes associated with differentiation progressively increase, including placental lactogen 2
(Prl3b1), glial cells missing homolog 1 (Gcm1), syncytin a (Syna), syncytin b (Synb), achaete-scute family
bHLH transcription factor 2 (Ascl2), and trophoblast-specific protein alpha (Tpbpa). These molecular
changes are precisely controlled in time and space, enabling differentiated trophoblasts to contribute
to specialized placental regions called the junctional zone (comprised of trophoblast giant cells,
spongiotrophoblasts, and glycogen cells), and labyrinth zone (which contains sinusoidal giant cells
and two syncytiotrophoblast layers) [7]. Each cell type is responsible for tasks that are critical for
placental function. For instance, trophoblast giant cells facilitate implantation and attachment of the
blastocyst to the uterine epithelium, as well as secretion of various hormones, which are responsible
for regulating development of both maternal and fetal compartments [8]. Glycogen cells differentiate
into an invasive phenotype, which migrate into the decidua and assist in remodeling the maternal
blood vessels so that the placenta is provided with an adequate supply of maternal blood throughout
gestation [8]. The syncytiotrophoblast layers contact maternal blood and form an exchange surface
to facilitate delivery of nutrients and oxygen into the fetal circulation. Disrupting the formation of
these cell types results in a malformed placenta and can be detrimental to the health of the fetus [7,9].
Thus, a better understanding of the mechanisms controlling TS cell development and differentiation
is necessary.
A family of OVO-like (OVOL) transcription factors is highly implicated in epithelial
development [10]. In mice and humans, there are three OVOL paralogs—Ovol1/OVOL1, Ovol2/OVOL2,
and Ovol3/OVOL3—that exhibit homology to Drosophila ovo/shavenbaby. The OVOL2 gene additionally
encodes three major isoforms (OVOL2A, OVOL2B, and OVOL2C) through distinct transcription start
sites and alternative splicing, which differ in transcriptional activity [11]. OVOL factors contain four
conserved C2H2 zinc finger domains at their C-terminal ends that facilitate DNA binding, but differ in
the structure of their N-terminal regions [12]. OVOL factors regulate differentiation of myriad epithelial
cell types including epidermis [13], hair follicles [14], kidney, spermatocytes [15], and mammary
epithelial cells [16]. Mutagenesis of Ovol1 and Ovol2 in mice has revealed some functional redundancy
as well as some critical tissue-specific differences. Notably, mice lacking OVOL1 die postnatally
due to dysregulated epidermis and kidney development [17]. Conversely, OVOL2 deficiency causes
embryonic lethality around embryonic day (E)10.5 resulting from major defects in blood vessel
expansion, heart formation, and placental development [18].
We previously demonstrated a critical role for OVOL1 in human syncytiotrophoblast formation.
However, we did not detect OVOL1 in mouse or rat placental tissue or in rodent TS cells [19].
Rodent placentas and TS cells, on the other hand, possessed high levels of OVOL2. The high expression
of OVOL2 in rodent placentas, fundamental role of OVOL factors for epithelial cell fate decisions, and
mid-gestation embryonic lethality with placentation defects observed in Ovol2-mutant mice prompted
us to investigate the functional role of OVOL2 for mouse TS cell development and placental formation.
Herein, we found a critical role for OVOL2 in TS cell differentiation and placental development in mice.
We also uncovered a novel pathway through which OVOL2 functions to facilitate TS cell differentiation,
involving repression of the gene encoding ID2.
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2. Materials and Methods
2.1. Animals
Male and female C57BL/6N and CD1 mice were obtained from Charles River Laboratories
(Wilmington, MA, USA). Ovol2+/- mice were previously described [18], and were generously provided
by Seiji Ito through RIKEN Bioresource Research Centre (Tsukuba, Ibaraki Prefecture, Japan) based
on a Materials Transfer Agreement. All mice were maintained in a 12 h light: 12 h dark cycle with
food and water available ad libitum. To induce pregnancy, males and females were placed into the
same cage overnight, and the presence of a seminal plug the following morning was designated E0.5.
Protocols involving the use of mice were approved by the University of Western Ontario Animal Care
and Use Committee, which was approved in March 2017 (protocol 2017-012).
2.2. Experimental Protocol and Tissue Collection
To evaluate expression patterns of OVOL2 in various fetal and placental tissues throughout
gestation, pregnant C57BL/6N mice were sacrificed on E9.5, E12.5, E15.5, and E18.5. Placentas and
embryos were collected at each time point, then immersed in dry ice-cooled heptane for
immunohistochemical analysis, or snap-frozen in liquid nitrogen for molecular analyses, and stored at
−80 ◦ C.
To determine the importance of OVOL2 for placental development, placental morphology was
evaluated in Ovol2+/+ , Ovol2+/- , and Ovol2-/- conceptuses. Ovol2+/- males were bred with wild-type
C57BL/6N females to maintain a stock of heterozygotes. To genotype pups, DNA was extracted from
tail clips using REDExtract-N-Amp Tissue PCR Kit (Sigma-Aldrich, Oakville, ON, Canada), according
to the manufacturer’s protocol. Polymerase chain reaction (PCR) was performed using DreamTaq
DNA polymerase (ThermoFisher Scientific, Mississauga, ON, Canada) and primers spanning the Ovol2
deletion site (Table 1). PCR conditions were as follows: initial holding step (95 ◦ C for 3 min), followed
by 32 cycles of PCR (95 ◦ C for 30 s, 63 ◦ C for 30 s, and 72 ◦ C for 30 s), and a final elongation phase at
72 ◦ C for 12 min. To obtain Ovol2+/+ , Ovol2+/- , and Ovol2-/- conceptuses, Ovol2+/- females were bred
with Ovol2+/- males. Embryos and placentas were collected on E9.5. Embryos were genotyped, and
placentas were either preserved in dry ice-cooled heptane or snap-frozen in liquid nitrogen, and stored
at −80 ◦ C.
For experiments involving generation of blastocyst-derived TS cells, Ovol2+/- females were bred
with Ovol2+/- males. On E3.5, blastocysts were collected by flushing uterine horns with M2 media
(Sigma Aldrich). TS cells were then derived from blastocysts, as described below. Mouse embryonic
fibroblasts (MEFs), which are required for TS cell culture, were prepared from E12.5 fetal tissue as
previously described [20]. Fetal tissue for preparation of MEFs was collected from CD-1 mice.
2.3. Cells
Media components for cell culture were obtained from Sigma-Aldrich unless otherwise specified,
and all cells were maintained in a temperature and gas-controlled incubator at 37 ◦ C, 5% CO2 .
MEFs were maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10%
fetal bovine serum (FBS, ThermoFisher Scientific), 100 units/mL penicillin, and 100 µM streptomycin.
To inhibit MEF proliferation, cells were treated with 5 µg/mL mitomycin C (M0503, Sigma-Aldrich)
for 2 h.
Mouse TS cells (F4 line) were generously provided by Janet Rossant, and were also generated
in-house following collection of blastocysts from Ovol2+/- × Ovol2+/- matings. TS cells were generated by
placing blastocysts onto cell culture plates containing mitotically inactivated MEFs in the presence of TS
cell media (Roswell Park Memorial Institute (RPMI)-1640 media supplemented with 20% FBS, 25 ng/mL
fibroblast growth factor 4 (235-F4-025, FGF4, R&D systems, Minneapolis, MN, USA), 1 µg/mL heparin,
10 ng/mL activin A (338-AC-10, R&D systems), 100 µM 2-mercaptoethanol, 100 mM sodium pyruvate,
100 units/mL penicillin, and 100 µM streptomycin). Once large aggregates of TS cells appeared in

Cells 2020, 9, 840

4 of 20

culture, cells were separated by mechanical dissociation, and passaged. MEFs were gradually depleted
from co-cultures by plating TS cells on gelatin-coated tissue culture plates. Subsequently, cells were
maintained in TS cell media, 70% of which was preconditioned by MEFs. DNA was isolated from TS
cells (Qiagen, Toronto, ON, Canada), and their genotype determined as described above.
TS cells were induced to differentiate by removal of MEF preconditioned media, FGF4, heparin, and
activin A (differentiation media) [20]. To stimulate TS cell differentiation toward the syncytiotrophoblast
II lineage (a sublineage of the labyrinth zone), cells were cultured in differentiation media, along with
a GSK3β inhibitor, CHIR99021 (3 µM, Stemgent, Cambridge, MA, USA) [21]. Controls for TS cells
exposed to CHIR99021 consisted of cells exposed to dimethyl sulfoxide (DMSO, 1:1000), which was
the vehicle used to prepare CHIR99021.
HEK-293T cells were maintained in DMEM supplemented with 10% FBS, 100 units/mL penicillin,
and 100 µM streptomycin. Cells were passaged by light trypsinization prior to reaching confluency.
2.4. Immunohistochemistry
Frozen mouse conceptuses were embedded in O.C.T. compound, cryosectioned at 10 µm, and
fixed in 4% paraformaldehyde. Sections were then treated with 0.3% hydrogen peroxide in methanol to
block endogenous peroxidases, permeabilized using 0.3% Triton-X, and blocked with 10% normal goat
serum (ThermoFisher Scientific). Sections were immersed in a primary antibody specific for cytokeratin
(628602, 1:400, BioLegend, San Diego, CA, USA), and then incubated with a mouse biotinylated
secondary antibody, followed by Vectastain peroxidase (Vector Laboratories, Burlingame, CA, USA).
Placental sections were then treated with an AEC Chromogen Solution (ThermoFisher Scientific), nuclei
counterstained with hematoxylin, and sections mounted using Fluoromount-G (Southern Biotech,
Birmingham, AL, USA). For fluorescent staining, sections were fixed and permeabilized as described
above, and incubated with antibodies specific for TPBPA (104401, 1:100, Abcam, Toronto, ON, Canada),
or cytokeratin conjugated to Alexa 488 (628608, 1:400, BioLegend). Sections immersed in antibodies
specific for TPBPA were washed and then incubated with Alexa 555-conjugated anti-rabbit secondary
antibodies. All sections were counterstained with 40 ,6-diamidino-2-phenylindole (DAPI, ThermoFisher
Scientific), mounted, and imaged using a Nikon DS-Qi2 microscope.
2.5. In Situ Hybridization
In situ hybridization was conducted using RNAScope, as per the manufacturer’s instructions
(Advanced Cell Diagnostics, Newark, CA, USA). Briefly, sections were hydrated through a graded
series of ethanol washes, subjected to peroxidase and protease treatment, and hybridized with probes
specific to mouse Ovol2. Additional sections treated with probes specific for mouse Ppib and bacterial
dapB served as positive and negative controls, respectively. Sections were then subjected to a series
of amplification steps, treated with 3,30 -diaminobenzidine chromogen solution, and nuclei were
counterstained with hematoxylin. Sections were dehydrated using increasing concentrations of ethanol,
cleared using xylene, mounted with Cytoseal (ThermoFisher Scientific), and imaged using a Nikon
DS-Qi2 microscope.
2.6. RT-PCR and Quantitative RT-PCR
RNA was extracted from cells and tissue using Ribozol (VWR International, Mississauga,
ON, Canada), according to the manufacturer’s instructions, and converted into cDNA via reverse
transcription (High Capacity cDNA kit, ThermoFisher Scientific). cDNA was diluted 1:10, then subjected
to conventional PCR or quantitative PCR using primers detailed in Table 1. Conventional PCR was
performed using DreamTaq DNA Polymerase (ThermoFisher Scientific). Cycling conditions involved
an initial holding step (95 ◦ C for 3 min), followed by 32 cycles of PCR (95 ◦ C for 30 s, 58–63 ◦ C for
30 s, and 72 ◦ C for 30 s), and a final elongation phase at 72 ◦ C for 12 min. Quantitative RT-PCR was
performed using a CFX96 Touch (Bio-Rad Laboratories, Mississauga, ON, Canada) and Sensifast
SYBR Green PCR Master Mix (FroggaBio, Toronto, ON, Canada). Cycling conditions involved an
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initial holding step (95 ◦ C for 10 min), followed by 40 cycles of a two-step PCR (95 ◦ C for 15 s and
60 ◦ C for 1 min) and a dissociation phase. Relative mRNA expression was calculated using the ∆∆Ct
method, using the geometric mean from two constitutively expressed genes, Rn18s and Ywhaz, as
reference RNAs.
Table 1. Forward and reverse primers used for RT-PCR and quantitative RT-PCR amplification.
Gene

Accession No.

Primers
50 -TGGAAGCACACCTTGACTGG-30

FWD:
REV: 50 -TGGACGTTTGCACCTTCAC-30

Product Size

Ascl2

NM_008554.3

Cdx2

NM_007673.3

FWD: 50 -CCAGCTCTTTGCCTCTCTGT-30
REV: 50 -TGCCTCTGGCTCCTGTAGTT-30

175

Eomes

NM_001164789.1

FWD: 50 -AACATGCAGGGCAATAAGATG-30
REV: 50 -AGCCTCGGTTGGTATTTGTG-30

172

Esrrb

NM_001159500.1

FWD: 50 -GGGAGCTTGTGTTCCTCATC-30
REV: 50 -CTACCAGGCGAGAGTGTTCC-30

200

50 -AACACCAACAACCACAACTCC-30

114

Gcm1

NM_008103.3

FWD:
REV: 50 -CAGCTTTTCCTCTGCTGCTT-30

151

Id2

NM_010496.3

FWD: 50 -CAGCATCCCCCAGAACAA-30
REV: 50 -TCTGGTGATGCAGGCTGA-30

121

50 -TGTTCCTTGGAGTCCCACCT-30

Ovol2 (RT-PCR)

NM_026924.3

FWD:
REV: 50 -ACTGACAACTTTGGGGTGCTT-30

426

Ovol2
(quantitative RT-PCR)

NM_026924.3

FWD: 50 -TTCACCCAGCGGTGTTCCTT-30
REV: 50 -TGTAGCCGCAATCCTCACAC-30

114

50 -CATAGCCCATGTGTGGCTGCTG-30

Ovol2 (Genotyping)

NM_026924.3

FWD:
REV: 50 -GCCGGCCTTAAAACATCCCAC-30

847

Prl3b1

NM_008865.3

FWD: 50 -CCAACGTGTGATTGTGGTGT-30
REV: 50 -TCTTCCGATGTTGTCTGGTG-30

175

Syna

NM_001013751.2

FWD: 50 -CCCTTGTTCCTCTGCCTACTC-30
REV: 50 -TCATGGGTGTCTCTGTCCAA-30

175

Synb

NM_173420.3

FWD: 50 -TGAACACCCCAACTGAGCAA-30
REV: 50 -GGACGAAACAGAGGACCCAA-30

123

Rn18s

NR_003278.3

FWD: 50 -GCAATTATTCCCCATGAACG-30
REV: 50 -GGCCTCACTAAACCATCCAA-30

122

Tpbpa

NM_009411.4

FWD: 50 -CGGAAGGCTCCAACATAGAA-30
REV: 50 -TCAAATTCAGGGTCATCAACAA-30

141

Ywhaz

NM_001253805.1

FWD: 50 -CCCTCTTGGCAGCTAATGG-30
REV: 50 -GGAGTAAGGGGAAAATGTGGG-30

116

2.7. Western Blotting
Cell and tissue lysates were prepared by immersing in radioimmunoprecipitation assay (RIPA)
lysis buffer (50 mM Tris, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulfate (SDS)) supplemented with protease inhibitor cocktail (Sigma-Aldrich). A modified bicinchoninic
acid assay (Bio-Rad Laboratories) was used to measure protein concentrations. Approximately 40 µg
of cell lysate was mixed with 4× reducing loading buffer (0.25 M Tris, 8% SDS, 30% glycerol, 0.02%
bromophenol blue, 0.3 M dithiothreitol), boiled for 5 min, and subjected to SDS-polyacrylamide gel
electrophoresis. Proteins were transferred to polyvinylidene difluoride membranes and probed using
antibodies for OVOL2 (GTX120220, 1:500, GeneTex, Irvine, CA, USA), ACTB (47778, 1:1000, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), and FLAG (F1804, 1:1000, Sigma-Aldrich). Membranes were
then incubated for 1 h with species-appropriate secondary antibodies, and signals detected using a
LI-COR Odyssey imaging system (LI-COR Biosciences, Lincoln, NE, USA).
2.8. Transfection
To ectopically express FLAG-tagged OVOL2 and ID2 in mouse TS cells, pCMV6-Entry constructs
containing the complete cDNA sequence of Ovol2 and Id2, each linked to a 30 -sequence encoding a
C-terminal FLAG tag, were obtained from OriGene (MR203678 and MR200792, respectively, Rockville,
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MD, USA). Plasmids (pCMV6-Empty and pCMV6-OVOL2) were transfected into HEK293T cells using
Lipofectamine 2000 (ThermoFisher Scientific), as described previously [22], to verify specificity of the
OVOL2 antibody used for Western blotting. Ovol2 and Id2 cDNAs were PCR amplified and cloned into
a pEF-GFP vector (Addgene catalog 11154, a generous gift from Connie Cepko) downstream of an EF1α
promoter. Mouse TS cells were transfected using jetPRIME transfection reagent (Polyplus Transfection,
New York, NY, USA) with 2 µg of either pEF-GFP (CTRL), pEF-OVOL2-FLAG, or pEF-ID2-FLAG
vectors, according to the manufacturer’s instructions. Briefly, plasmids were added to 200 µL jetPRIME
buffer, mixed with 8 µL jetPRIME transfection reagent, and incubated for 10 min. Following incubation,
the transfection mix was added dropwise to TS cells in TS cell media. Quantitative RT-PCR and/or
Western blotting were performed as described above to determine successful transfection of Ovol2
or Id2.
2.9. EdU Cell Proliferation Assay
A 5-ethynyl-20 -deoxyuridine (EdU) incorporation assay was conducted to assess TS cell
proliferation and was performed according to the manufacturer’s instructions (Click-iT EdU Cell
Proliferation Assay, ThermoFisher Scientific). Briefly, 10 µM EdU was added to TS cell media, and
provided to cells for 72 h. Following incubation, mouse TS cells were fixed in 4% paraformaldehyde,
permeabilized using 0.3% Triton-X, and incubated with Click-iT EdU reaction cocktail for 30 min. Nuclei
were stained using Hoechst 33342. Cells were imaged using a Zeiss Axio fluorescence microscope.
2.10. Chromatin Immunoprecipitation
Chromatin Immunoprecipitation (ChIP) was performed as previously described [19]. Mouse TS
cells (F4 line) were differentiated for three days, fixed for 10 min with 0.7% formaldehyde, lysed, and
sonicated using a Bioruptor (Diagenode, Denville, NJ, USA) to generate DNA fragments less than
400 bp. 1% of sonicated nuclear lysate was removed to serve as an input control. Half of the remaining
lysate was incubated with OVOL2 antibody (5 µg, GTX120220, GeneTex); the other half was incubated
with a negative control rabbit IgG (5 µg, 2729, Cell Signaling Technology, Danvers, MA, USA) overnight
at 4 ◦ C. Immunoprecipitated chromatin fragments were then captured using protein G-conjugated
Sepharose beads (Sigma-Aldrich). Following capture, DNA fragments were eluted and assessed by
quantitative PCR. Values were normalized relative to input. Primers specific for regions of DNA that
span the consensus OVOL2 DNA-binding motif, CCGTTA [12], are found in Table 2.
Table 2. Forward and reverse primers used for ChIP.
Gene

CCGTTA

Primers
50 -CTTCCTCCTACGAGCAGCAT-30

+25

FWD:
REV: 50 -GGTCCGACAGGCTGTTTTT-30

Eomes

−3193

FWD: 50 -TTCCAGAGTCCAGGCAAAGT-30
REV: 50 -TGCTGCATGCTCTCCTTTTA-30

Esrrb

−1477

FWD: 50 -TTGAGCACCCATTCAAACAC-30
REV: 50 -ATGCAGGTAAACGCCATGTT-30

Id2

2.11. Luciferase Assay
A section of the mouse Id2 promoter (from -1420 to +153) containing a putative OVOL2 binding
site was cloned upstream of firefly luciferase into a pGL2-Luc vector (E1641, Promega, Madison,
WI, USA). HEK-293T cells were transfected using Lipofectamine 2000 (ThermoFisher), as previously
described [22], with 100 ng of pGL2-Luc-Id2 vector along with 100 ng of either the CTRL plasmid
(described above) or a plasmid encoding FLAG-tagged OVOL2 (pEF-OVOL2-FLAG). After 48 h, cells
were lysed using the Bright-Glo Luciferase Assay System (E2610, Promega) and luciferase activity was
measured using a luminescence microplate reader.
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2.12. Statistical Analysis
To quantify placental depth and area, immunohistochemistry was conducted on Ovol2+/+ , Ovol2+/
and Ovol2-/- placental sections to detect cytokeratin-positive trophoblasts. Images were imported
into ImageJ (Version 1.50i) [23], and analyzed. Placental area was measured by capturing the
number of pixels in the image that were positive for cytokeratin. Placental depth was measured
by determining the number of pixels in a straight line from the bottom of the placenta (chorionic
plate) to the top. Each placenta was measured three independent times, and measurements averaged.
Statistical comparisons between two means were tested using Student’s t-test and statistical comparisons
between three or more means were tested using Analysis of Variance, followed by a Tukey’s post-hoc
test. Means were considered statistically different if P was less than 0.05. GraphPad Prism 6.0 was used
for all graphing and statistical analysis. All experiments were repeated at least three independent times.
3. Results
3.1. OVOL2 Is Highly Expressed in Mouse Placenta
To analyze expression of Ovol2 in the developing mouse conceptus at various times during
gestation, RT-PCR was performed on placenta and embryos at E9.5, E12.5, and E15.5. On E18.5, Ovol2
expression in placenta and various fetal organs (liver, skin, heart, brain, intestine) was evaluated.
Ovol2 was highly expressed in placenta at all time points. In embryos, we were unable to detect
expression on E9.5, 12.5, and 15.5 at the PCR conditions used in this study. On E18.5, Ovol2 was
detectable in skin, but was low or undetectable in liver, heart, intestine, and brain (Figure 1A).
Similar results were obtained using quantitative RT-PCR, in which the highest expression levels were
found in placenta, followed by fetal skin (Figure S1). When assessed at the protein level, OVOL2 was
highly expressed in mouse placenta throughout gestation (Figure 1B; note that the lower band likely
represents a degradation product, as shown in [24]. Verification that antibody detects OVOL2 is shown
in Figure S2). The molecular weight of OVOL2 in mouse placenta was approximately 37 kDa, which is
consistent with the OVOL2A isoform that has transcriptional repressor activity [10]. Next, to determine
localization of Ovol2 in mouse placenta, we performed in situ hybridization on serial sections of mouse
placenta throughout gestation. Ovol2 was strongly detected in the chorioallantoic placenta at E9.5, and
in the labyrinth zone in E12.5, E15.5, and E18.5 placentas (Figure 1C; data only shown for E9.5 and
E12.5. Cytokeratin was used to identify trophoblasts). Expression of Ovol2 was low or undetectable in
the decidua, junctional zone, and chorionic plate at all time points.
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To determine the importance of OVOL2 for placental development, Ovol2-heterozygous male
female mice were bred to obtain wild-type, Ovol2-heterozygous, and Ovol2-null placentas. On E9.5
and female mice were bred to obtain wild-type, Ovol2-heterozygous, and Ovol2-null placentas. On
(prior to embryonic death on or after E10.5), Ovol2-null placentas were readily detectable, but were
E9.5 (prior to embryonic
death on or after E10.5), Ovol2-null placentas were readily detectable, but
already smaller, paler,Fig.
and1. poorly formed when compared to their wild-type siblings (Figure 2A).
were already smaller, paler, and poorly formed when compared to their wild-type siblings (Figure
Using cytokeratin as a marker for all trophoblast lineages, we determined that Ovol2-null placentas
2A). Using cytokeratin as a marker for all trophoblast lineages, we determined that Ovol2-null
have significantly reduced depth and area (65% and 63% decreased compared to wild-type placentas,
placentas have significantly reduced depth and area (65% and 63% decreased compared to wild-type
Figure 2B, N = 4, P < 0.05). Since OVOL factors control differentiation of various epithelial lineages,
placentas, Figure 2B, N = 4, P < 0.05). Since OVOL factors control differentiation of various epithelial
we next evaluated expression of various genes associated with trophoblast stem and differentiation
lineages, we next evaluated expression of various genes associated with trophoblast stem and
states in wild-type, Ovol2-heterozygous, and Ovol2-null placentas on E9.5. TS cell stem markers
differentiation states in wild-type, Ovol2-heterozygous, and Ovol2-null placentas on E9.5. TS cell stem
Id2, Esrrb, and Eomes were significantly upregulated in Ovol2-null placentas by 36%, 63%, and 77%,
markers Id2, Esrrb, and Eomes were significantly upregulated in Ovol2-null placentas by 36%, 63%,
respectively, when compared to wild-type placentas (Figure 2C, N = 3, P < 0.05). There was no change
and 77%, respectively, when compared to wild-type placentas (Figure 2C, N = 3, P < 0.05). There was
in expression of the TS cell marker Cdx2 between wild-type and Ovol2-null placentas, indicating
no change in expression of the TS cell marker Cdx2 between wild-type and Ovol2-null placentas,
that only selected stem-related transcripts are up-regulated in placentas lacking OVOL2. Ovol2-null
indicating that only selected stem-related transcripts are up-regulated in placentas lacking OVOL2.
placentas also showed reduced expression of labyrinth zone markers (78% and 68% decreased Synb
Ovol2-null placentas also showed reduced expression of labyrinth zone markers (78% and 68%
and Gcm1 expression, respectively) and junctional zone-associated transcripts (68% and 82% decreased
decreased Synb and Gcm1 expression, respectively) and junctional zone-associated transcripts (68%
and 82% decreased Prl3b1 and Tpbpa expression, respectively, Figure 2C, all N = 3, P < 0.05). Lastly,
we performed immunohistochemistry for TPBPA, a protein expressed by a subset of differentiated
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Prl3b1 and Tpbpa expression, respectively, Figure 2C, all N = 3, P < 0.05). Lastly, we performed
immunohistochemistry for TPBPA, a protein expressed by a subset of differentiated trophoblasts.
trophoblasts. In comparison to robust expression of TPBPA evident in wild-type placentas, TPBPA
In comparison to robust expression of TPBPA evident in wild-type placentas, TPBPA was barely
was barely detectable in Ovol2-null placentas, suggesting poor trophoblast differentiation in Ovol2detectable in Ovol2-null placentas, suggesting poor trophoblast differentiation in Ovol2-null conceptuses
null conceptuses (representative images of TPBPA immunohistochemistry conducted on four wild(representative images of TPBPA immunohistochemistry conducted on four wild-type and Ovol2-null
type and Ovol2-null placentas is presented in Figure 2D). Collectively, these results indicate that
placentas is presented in Figure 2D). Collectively, these results indicate that Ovol2-null placentas have
Ovol2-null placentas have impaired placental development with evidence of poor trophoblast
impaired placental development with evidence of poor trophoblast differentiation.
differentiation.

A

B
DAPI

Merge

Cytokeratin

E9.5 Null

E9.5 WT

Ovol2

C

Junctional Zone

D
DAPI/TPBPA DAPI/TPBPA

TPBPA

E9.5 WT

Labyrinth Zone

E9.5 Null

Relative Expression

Stem

Low
Magnification

High
Magnification

Figure
Figure 2.
2. Placental
Placentaldevelopment
developmentisisimpaired
impairedininOvol2-deficient
Ovol2-deficientembryos.
embryos.(A)
(A)Evaluation
Evaluationof
of Ovol2
Ovol2
expression
in
wild-type
(WT)
and
Ovol2-null
placentas
on
E9.5.
Immunohistochemical
staining
expression in wild-type (WT) and Ovol2-null placentas on E9.5. Immunohistochemical stainingof
of
cytokeratin
to denote
denotethe
thelocation
locationofofplacentas.
placentas.Note
Note
poor
placental
development
in Ovol2cytokeratin was
was used
used to
poor
placental
development
in Ovol2-null
null
placentas.
Quantitative
analysis
placentalarea
areaand
anddepth
depthcomparing
comparing WT and Ovol2-null
placentas.
(B) (B)
Quantitative
analysis
of of
placental
Ovol2-null
placentas.
(C)
Transcript
analysis
of
stem
(Cdx2,
Eomes,
Esrrb,
and
Id2)
and
differentiation
placentas. (C) Transcript analysis of stem (Cdx2, Eomes, Esrrb, and Id2) and differentiation markers
markers
(Gcm1,
(Gcm1,Synb,
Synb,Prl3b1,
Prl3b1,and
andTpbpa)
Tpbpa)comparing
comparingWT,
WT,heterozygote
heterozygote(Het),
(Het),and
andOvol2-null
Ovol2-nullplacentas
placentasatatE9.5.
E9.5.
(D)
(D)Immunohistochemical
Immunohistochemicalstaining
stainingofofdifferentiation
differentiationmarker
markerTPBPA
TPBPAin
inWT
WTand
andOvol2-null
Ovol2-nullplacentas.
placentas.
Values
Values significantly
significantly different
different from
from WT
WT (N
(N ==3–4
3–4from
from different
different dams,
dams, PP <<0.05)
0.05)are
aredenoted
denotedwith
withan
an
asterisk
Scalebars
bars= =500
500
magnification)
andµm
100
µmmagnification).
(high magnification).
Graphs
asterisk (*). Scale
µmµm
(low(low
magnification)
and 100
(high
Graphs represent
represent
means (SD).
means
Fig. 2. (SD).

3.3. Ovol2 Is Induced during Differentiation of Mouse TS Cells
Next, we evaluated expression patterns of OVOL2 during mouse TS cell differentiation. To
confirm the efficiency of our TS cell differentiation protocol, we performed quantitative RT-PCR to
detect expression of various genes associated with stem and differentiated states in TS cells cultured
under stem conditions or following differentiation for up to 14 days. Differentiation of TS cells was
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3.3. Ovol2 Is Induced during Differentiation of Mouse TS Cells
Next, we evaluated expression patterns of OVOL2 during mouse TS cell differentiation. To confirm
the efficiency of our TS cell differentiation protocol, we performed quantitative RT-PCR to detect
expression of various genes associated with stem and differentiated states in TS cells cultured under
stem conditions or following differentiation for up to 14 days. Differentiation of TS cells was associated
with a rapid reduction in expression of stem-state associated genes Cdx2, Eomes, Esrrb, and Id2
(approximately 90-fold reduction in expression of these genes after culturing for seven days in
differentiation conditions compared to stem conditions, Figure 3A, N = 6, P < 0.05), and increased
expression of differentiation markers associated with the labyrinth zone (Gcm1 and Synb; upregulated
by 180-fold and 10-fold, respectively; Figure 3B, N = 6, P < 0.05) and junctional zone (Prl3b1 and Tpbpa;
upregulated by 5824-fold and 4370-fold, respectively; Figure 3C, N = 6, P < 0.05). Interestingly, TS
cells exposed to differentiation conditions showed a 40-fold upregulation of Ovol2 transcript when
compared to TS cells cultured in stem conditions (Figure 3D, N = 6, P < 0.05). OVOL2 protein was
detected in both stem and differentiation conditions, but expression was more robust following TS cell
differentiation (Figure 3E), which is consistent with the increased expression of Ovol2 mRNA.
Although mouse TS cells differentiate into all trophoblast lineages, the standard differentiation
protocol (removal of FGF4, heparin, activin A, and MEF-conditioned media) preferentially induces
trophoblast giant cell formation. Therefore, we used another differentiation protocol, in which TS cells
were exposed to differentiation conditions in the presence of the GSK3β inhibitor CHIR99021, which
stimulates TS cells to differentiate towards the syncytiotrophoblast II lineage [20]. Following four
days of TS cell differentiation in the presence of CHIR99021, stem markers Cdx2 and Eomes were
significantly decreased (91% and 92% decrease compared to untreated controls, Figure S3A, N = 3,
P < 0.05). The junctional zone-associated transcript, Prl3b1, was significantly upregulated by 93% when
compared to the untreated control, which was comparable to the expression of Prl3b1 following TS cell
differentiation for four days without CHIR99021 (Figure S3B, N = 3, P < 0.05). When syncytiotrophoblast
layer II markers were analyzed, expression of Gcm1 and Synb increased in cells cultured in differentiation
conditions for four days (5.4-fold and 16.3-fold increased expression compared to TS cells cultured in
stem conditions, respectively; Figure S3C, N = 3, P < 0.05). However, when TS cells were cultured
in differentiation conditions in the presence of CHIR99021, expression of Gcm1 and Synb was much
more pronounced (225-fold and 2444-fold increased expression compared to TS cells cultured in
stem conditions, respectively, Figure S3C, N = 3, P < 0.05). On the other hand, Syna, a marker of
syncytiotrophoblast layer I, was upregulated by 82.7-fold in TS cells differentiated for four days under
standard differentiation conditions, but was only upregulated by 7.2-fold in differentiated TS cells
treated with CHIR99021, when compared to undifferentiated TS cells (Figure S3C, N = 3, P < 0.05).
These results show that CHIR99021 facilitates TS cell differentiation toward the syncytiotrophoblast II
lineage. When we analyzed Ovol2 expression, in comparison to TS cells cultured in stem conditions,
both the standard differentiation protocol and addition of CHIR99021 upregulated Ovol2 expression
by approximately 7-fold after four days in comparison to undifferentiated TS cells (Figure S3D,
N = 3, P < 0.05). These results suggest that both TS cell differentiation protocols induce Ovol2
expression. Therefore, for the duration of this study, only the standard differentiation protocol was
used for experiments.

expression of differentiation markers associated with the labyrinth zone (Gcm1 and Synb; upregulated
by 180-fold and 10-fold, respectively; Figure 3B, N = 6, P < 0.05) and junctional zone (Prl3b1 and Tpbpa;
upregulated by 5824-fold and 4370-fold, respectively; Figure 3C, N = 6, P < 0.05). Interestingly, TS
cells exposed to differentiation conditions showed a 40-fold upregulation of Ovol2 transcript when
compared to TS cells cultured in stem conditions (Figure 3D, N = 6, P < 0.05). OVOL2 protein was
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detected in both stem and differentiation conditions, but expression was more robust following11TS
cell differentiation (Figure 3E), which is consistent with the increased expression of Ovol2 mRNA.
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Figure 3. Increased expression of OVOL2 during mouse TS cell differentiation. Quantitative RT-PCR
Figure
3. Increased expression of OVOL2 during mouse TS cell differentiation. Quantitative RT-PCR
analysis of (A) stem (Cdx2, Eomes, Esrrb, and Id2) and differentiation markers for the (B) labyrinth
analysis of (A) stem (Cdx2, Eomes, Esrrb, and Id2) and differentiation markers for the (B) labyrinth zone
Fig. 3.(Gcm1, Synb) and (C) junctional zone (Prl3b1 and Tpbpa) in mouse TS cells cultured under stem or
differentiation conditions for up to 14 days. (D) Quantitative RT-PCR and (E) and Western blot analysis
of OVOL2 expression in mouse TS cells cultured under stem or differentiation conditions for up to 14
days. ACTB was used as a loading control for Western blots. Values significantly different from stem
conditions (N = 6, P < 0.05) are indicated with an asterisk (*). Graphs represent means (SD).

3.4. Ectopic Expression of OVOL2 Drives Precocious TS Cell Differentiation
Since Ovol2 expression increased during TS cell differentiation, we next determined whether
increased expression of OVOL2 was sufficient per se to drive differentiation of mouse TS cells.
We ransfected TS cells with either a CTRL plasmid, or a plasmid encoding OVOL2 with a C-terminal
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FLAG tag. Mouse TS cells ectopically expressing OVOL2-FLAG showed a 54-fold increase in Ovol2
expression compared to CTRL cells cultured in stem conditions (Figure 4A, N = 3, P < 0.05). Ectopic
OVOL2-FLAG expression was also confirmed at the protein level (Figure 4B). Since higher expression of
OVOL2 was apparent in TS cells transfected with OVOL2-FLAG, these cells will henceforth be referred
to as OVOL2 overexpression (OVOL2 OE) cells. To determine whether increased OVOL2 drives TS
cell differentiation, we analyzed expression of genes associated with the trophoblast stem state (Cdx2,
Eomes, and Id2), as well as labyrinth and junctional zone markers (Gcm1, Syna, Synb, Prl3b1, Tpbpa) in
CTRL and OVOL2 OE cells cultured in the stem state, or following a 1-day exposure to differentiation
conditions. OVOL2 OE cells had reduced Eomes and Id2 expression in stem conditions by 53% and 36%,
respectively, when compared to CTRL cells (Figure 4C, N = 3, P < 0.05). No change was apparent in
Eomes and Id2 transcript expression between CTRL and OVOL2 at 1 day of differentiation (Figure 4C,
N = 3). Cdx2 showed no change between CTRL and OVOL2 OE cells at either time point (data not
shown). We next assayed expression of genes associated with differentiation of TS cells. Compared to
CTRL cells, OVOL2 OE cells had increased Synb expression when cultured in the stem state (2.8-fold
increase,
4D, N = 3, P < 0.05), and increased expression of Gcm1, Synb, and Prl3b1 following
Cells
2020, 9,Figure
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determine
requirement
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forcell
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differentiation.
To
generate
Ovol2-null
TS
cells,
blastocysts
from
male
and
female
Ovol2-heterozygous
differentiation. To generate Ovol2-null TS cells, blastocysts from male and female Ovol2-heterozygous
matings were collected, cultured on MEFs, and disaggregated several times to promote formation of
TS cells. Wild-type and Ovol2-heterozygous TS cells formed tight colonies with morphologies
consistent with typical TS cell behavior. Ovol2-null TS cells, on the other hand, formed enormous TS
cell aggregates that seemed to proliferate approximately twice as fast compared to wild-type or
Ovol2-heterozygote TS cells (Figure 5, phase-contrast images). To evaluate TS cell proliferative
potential, we performed an EdU incorporation assay. In comparison to both wild-type and Ovol2-
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matings were collected, cultured on MEFs, and disaggregated several times to promote formation of TS
cells. Wild-type and Ovol2-heterozygous TS cells formed tight colonies with morphologies consistent
with typical TS cell behavior. Ovol2-null TS cells, on the other hand, formed enormous TS cell aggregates
that seemed to proliferate approximately twice as fast compared to wild-type or Ovol2-heterozygote
TS cells (Figure 5, phase-contrast images). To evaluate TS cell proliferative potential, we performed an
EdU incorporation assay. In comparison to both wild-type and Ovol2-heterozygous TS cells, a greater
percentage of Ovol2-null TS cells incorporated EdU (approximately 2-fold increased EdU incorporation
compared to wild-type and Ovol2-heterozygous TS cells, respectively, Figure 5, N = 3, P < 0.05),
indicating that Ovol2-null TS cells proliferated at a faster rate than wild-type or Ovol2-heterozygous
TS cells. Since wild-type and Ovol2-heterozygous TS cells had similar morphologies and levels of
proliferation, subsequent experiments were conducted using Ovol2-heterozygous and Ovol2-null
TS
Cellscells.
2020, 9, x
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Figure 5. Ovol2-null TS cells exhibit increased proliferation. Representative phase-contrast images
Figure 5. Ovol2-null TS cells exhibit increased proliferation. Representative phase-contrast images
(left panels) of wild-type (WT), Ovol2-heterozygote (Het), and Ovol2-null mouse TS cells. Detection of
(left panels) of wild-type (WT), Ovol2-heterozygote (Het), and Ovol2-null mouse TS cells. Detection of
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heterozygotes, Figure 6B, N = 3, all P < 0.05). These results indicate that Ovol2-null TS cells are arrested
in the stem state and are incapable of differentiating into the various lineages of the mouse placenta.
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These results indicate that Ovol2-null TS cells are arrested in the stem state and are incapable of
differentiating
into the various lineages of the mouse placenta.
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3.6. OVOL2 Binds Upstream of Id2 and Represses Its Activity
3.6. OVOL2 Binds Upstream of Id2 and Represses Its Activity
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downstream of the transcription start site. Using wild-type TS cells, we were unable to detect OVOL2
binding upstream of either Eomes or Esrrb, but detected robust binding within Id2 (Figure 7A, N = 3,
P < 0.05), indicating that the Id2 gene is a direct transcriptional target of OVOL2. Subsequently, we
cloned a sequence of the mouse Id2 promoter (including the OVOL2 binding region) upstream of
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or Esrrb, but detected robust binding within Id2 (Figure 7A, N = 3, P < 0.05), indicating that the Id2
of 20
gene is a direct transcriptional target of OVOL2. Subsequently, we cloned a sequence of the 15
mouse
Id2 promoter (including the OVOL2 binding region) upstream of firefly luciferase and transfected
firefly luciferase and transfected this vector into HEK-293T cells along with either the CTRL or
this vector into HEK-293T cells along with either the CTRL or OVOL2-FLAG expression plasmids. In
OVOL2-FLAG expression plasmids. In cells transfected with OVOL2-FLAG, the ability of the Id2
cells transfected with OVOL2-FLAG, the ability of the Id2 promoter to drive luciferase activity was
promoter to drive luciferase activity was reduced by 87% compared to cells transfected with the
reduced by 87% compared to cells transfected with the CTRL vector, strongly suggesting that OVOL2
CTRL vector, strongly suggesting that OVOL2 represses the activity of the Id2 promoter (Figure 7B,
represses the activity of the Id2 promoter (Figure 7B, N = 3, P < 0.05). Finally, to determine whether
N = 3, P < 0.05). Finally, to determine whether ID2 is critical for promoting the stem state in TS cells,
ID2 is critical for promoting the stem state in TS cells, we ectopically expressed Id2 in mouse TS cells.
we ectopically expressed Id2 in mouse TS cells. Ectopic expression of Id2 elicited a 2.7-fold increased
Ectopic expression of Id2 elicited a 2.7-fold increased expression of Id2 compared to TS cells transfected
expression of Id2 compared to TS cells transfected with the CTRL plasmid (Figure 7C, N = 3, P < 0.05).
with the CTRL plasmid (Figure 7C, N = 3, P < 0.05). TS cells expressing increased Id2 did not exhibit
TS cells expressing increased Id2 did not exhibit changes in expression of Cdx2 or various
changes in expression of Cdx2 or various differentiation markers but displayed a 1.5-fold and 1.7-fold
differentiation markers but displayed a 1.5-fold and 1.7-fold increased expression in Eomes and Esrrb,
increased expression in Eomes and Esrrb, respectively (Figure 7C, N = 3, P < 0.05). Our results suggest
respectively (Figure 7C, N = 3, P < 0.05). Our results suggest that ID2 enhances expression of Eomes
that ID2 enhances expression of Eomes and Esrrb, thereby reinforcing the TS cell stem state.
and Esrrb, thereby reinforcing the TS cell stem state.
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the control of TS cell fate during placental development.
In our first series of experiments, we investigated expression and localization patterns of OVOL2
Fig. 7.
in mouse conceptuses (including decidua, placenta, and embryo) throughout gestation. We detected
high expression of Ovol2 in the labyrinth zone of the placenta throughout gestation, which is
consistent with other studies [18,19,25]. In early gestation (E9.5–E15.5) embryos, Ovol2 expression
was low or undetectable at the PCR conditions used in our study, although we cannot conclude that
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In our first series of experiments, we investigated expression and localization patterns of OVOL2
in mouse conceptuses (including decidua, placenta, and embryo) throughout gestation. We detected
high expression of Ovol2 in the labyrinth zone of the placenta throughout gestation, which is consistent
with other studies [18,19,25]. In early gestation (E9.5–E15.5) embryos, Ovol2 expression was low or
undetectable at the PCR conditions used in our study, although we cannot conclude that it is not
expressed. A previous study showed low expression levels of OVOL2 in embryonic tissue throughout
gestation [18]. In E18.5 embryos, expression of Ovol2 was readily detected in skin but was low in heart,
liver, intestine, and brain, which is consistent with other reports describing its restricted expression
patterns [10]. The high expression of OVOL2 in placenta throughout gestation suggests that this
transcription factor has an important role in placental development and/or function. Indeed, mice
lacking OVOL2 exhibit embryonic lethality around E10.5 associated with major defects in blood vessel
expansion in the labyrinth zone, placental formation, and heart development [18]. When analyzing
conceptuses on E9.5, we observed that Ovol2-deficient placentas were noticeably smaller, paler, and
exhibited decreased area and depth compared to wild-type placentas. Interestingly, compared to
wild-type placentas, Ovol2-null placentas exhibited elevated expression of several genes associated
with the TS cell stem state, including Id2, Eomes, and Esrrb. Notably, there was no difference in Cdx2
expression, indicating that Ovol2 deficiency likely only impacts expression of a subset of trophoblast
stem-related genes. We also found decreased expression of various genes associated with differentiated
trophoblasts (Gcm1, Prl3b1, Synb, and Tpbpa) in Ovol2-null placentas compared to wild-type placentas.
It should be noted that previous studies detected Tpbpa and Gcm1 in Ovol2-null placentas [18] and
concluded that expression was similar to Ovol2-heterozygous placentas, although these experiments
were conducted using in situ hybridization so expression levels of these genes were not quantified.
Our immunohistochemical analysis of TPBPA, a marker of differentiated trophoblasts populating
the junctional zone [9], shows a strong reduction in protein expression in Ovol2-null placentas,
suggesting that these placentas may lack developmental cues required for trophoblast differentiation.
Since Ovol2-null placentas develop poorly and exhibit gene expression profiles consistent with poor
trophoblast development, we next investigated the role of OVOL2 in the control of TS cell function.
Mouse TS cells can be derived from preimplantation blastocysts or extraembryonic ectoderm
and propagated in vitro; they represent the precursor cells of all specialized trophoblast lineages.
Since culture conditions that favor mouse TS cell self-renewal or differentiation have been known
for decades, these cells have provided the best studied in vitro models to investigate development of
trophoblast lineages. Using two separate differentiation protocols, we induced mouse TS cells to either
undergo conventional differentiation [4], or differentiate to preferentially form cells representative of
the syncytiotrophoblast layer II lineage [21]. We found that Ovol2 mRNA levels robustly increased
during both TS cell differentiation protocols. OVOL2 protein was detectable in TS cells cultured in the
stem state, and expression increased following induction of TS cell differentiation. Moreover, we found
that ectopic expression of OVOL2 was sufficient to prime TS cells to undergo precocious differentiation,
including decreased levels of stem-related genes Id2 and Eomes, and increased expression of Gcm1,
Synb, and Prl3b1. However, not all differentiation-associated genes (e.g., Syna) were induced in OVOL2
OE cells, indicating that OVOL2 may not be sufficient by itself to stimulate full-fledged TS cell
differentiation. This trend was observed at early stages of differentiation but was imperceptible by
three and five days of differentiation (not shown), likely relating to high levels of endogenous OVOL2
in differentiating trophoblasts by these time points. Interestingly, TS cells lacking the transcriptional
regulator lysine-specific demethylase 1 exhibit precocious trophoblast differentiation and migration
attributed to increased expression of Ovol2, further suggesting that increased OVOL2 is sufficient to
drive TS cell differentiation [26].
To determine whether OVOL2 is required for TS cell differentiation, we generated TS cells from
Ovol2-heterozygous and Ovol2-null blastocysts. Ovol2-heterozygous TS cells formed classic TS cell
colonies that were morphologically indistinguishable from wild-type TS cells. On the other hand,
Ovol2-null TS cells seemed to proliferate vigorously, and required passaging at a rate two-to-three
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times more frequently than wild-type or heterozygous TS cells. When we assessed levels of trophoblast
stem-related genes, Ovol2-null TS cells exhibited much higher levels of Eomes, Esrrb, and Id2 than
Ovol2-heterozygous TS cells. These results suggest that in the absence of OVOL2, TS cells acquire
more proficient stem-like properties, which may explain the higher proliferative index in these cells.
Our findings that OVOL2 suppresses TS cell proliferation are consistent with the known tumor
suppressor functions of OVOL2 in other cell types [27]. OVOL2 inhibits cell proliferation and protects
epithelial identity by regulating Wnt signaling [14,28–30], repressing oncogenes (e.g., c-Myc) [24],
and reducing expression of genes associated with epithelial-to-mesenchymal transition [16,27,31–34].
Interestingly, in our study, expression of Eomes, Esrrb, and Id2 remained higher in Ovol2-null TS
cells even when cultured in differentiation conditions, resulting in diminished capacity to upregulate
differentiation markers including Gcm1, Syna, Prl3b1, and Ascl2. The poor differentiation potential of
TS cells lacking OVOL2 is likely responsible for failure of proper morphogenesis in Ovol2-deficient
placentas, and may also contribute to the poor vascularization in the labyrinth zone that was described
previously [18].
OVOL2A contains an N-terminal SNAG repressor motif and four C-terminal C2H2 zinc finger
domains that confer DNA binding activity [10,12], and acts as a transcriptional repressor [16]. Therefore,
to identify putative transcriptional targets of OVOL2 binding, we performed in silico analysis of
OVOL2 consensus sequences in the proximal promoter regions of three genes that consistently showed
increased expression in Ovol2-deficient placentas and TS cells: Eomes, Esrrb, and Id2. While putative ovo
binding motifs were detected near all three genes, we only detected OVOL2 binding within Id2, resulting
in repression of Id2 promoter activity. Id2 encodes a dominant-negative helix-loop-helix protein that
prevents cell differentiation in numerous developmental pathways by preventing DNA binding of
other basic helix-loop-helix transcription factors [35,36]. Id2 has previously been identified as a target
of OVOL1-mediated repression during progression through the pachytene stage of spermatogenesis.
Similar to our findings in Ovol2-deficient trophoblasts, Ovol1-deficient spermatogonia express high
levels of Id2, and exhibit a reduced capacity to exit the cell cycle and commence differentiation [37].
Using a published ChIP-Sequencing dataset [16], we also detected OVOL2 enrichment near the Id2
gene in mouse mammary epithelial cells, suggesting that OVOL factors may regulate Id2 transcription
in a variety of tissues. Although mice lacking ID2 are viable and fertile, ID1 and ID3 are also expressed
in mouse placenta. Mice lacking multiple ID proteins are embryonic lethal, suggesting compensatory
actions of other ID family members (reviewed in [38]). Studies have not yet investigated whether
placental defects are evident in mice lacking multiple ID isoforms. However, ID2 is the earliest
transcriptional regulator specifically expressed in the nascent trophectoderm, suggesting a critical role
for ID2 in maintenance of the TS cell state ([39]). The importance of ID2 repression for trophoblast
differentiation has been previously demonstrated in the mouse SM10 labyrinth trophoblast progenitor
cell line, in which overexpression of ID2 prevents differentiation [40]. Expression of ID2 is also highly
expressed in human cytotrophoblasts, and ID2 expression decreases during differentiation in vitro and
in situ. Overexpression of ID2 is sufficient to prevent differentiation of human cytotrophoblasts and
cell-lines [41–43]. Consistent with these studies, we found that ectopic expression of ID2 in TS cells
was sufficient to drive increased levels of stem state-associated transcripts. Although it is likely that
Id2 is not the only transcriptional target of OVOL2-mediated repression in TS cells, our results strongly
implicate repression of Id2 as a mechanism through which OVOL2 transitions these cells towards a
differentiated phenotype.
In conclusion, we identified a critical function of OVOL2 for the progression of TS cell differentiation
during placental morphogenesis. OVOL2 represses Id2 and appears to serve as a gatekeeper that
enables TS cells to switch from a stem state to a differentiated phenotype. In essence, OVOL2 serves
a role in mouse trophoblast development that parallels the function of OVOL1 in the promotion of
human cytotrophoblast differentiation [19]. In future studies, it would be interesting to determine
whether other genes besides Id2 are targeted for repression by OVOL2 during TS cell differentiation,
and also identify how ID2 functions to reinforce the TS cell stem state. Given the high expression of
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OVOL2 in mouse placenta and compelling effects on TS cell behavior, it is tempting to speculate that
failure of TS cell differentiation during placental morphogenesis could contribute, at least in part, to
the vascular deficiencies and embryonic lethality observed in Ovol2-deficient embryos.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4409/9/4/840/s1,
Figure S1: Quantitative analysis of Ovol2 expression in mouse placenta and embryo throughout gestation, Figure S2:
Verification of OVOL2 antibody, Figure S3: Transcript analysis of mouse TS cells cultured under stem conditions
versus two differentiation protocols.
Author Contributions: M.J.J. and S.J.R. designed and conceptualized the study. M.J.J., G.J.B., and D.M.H.
performed experiments. M.J.J. and S.J.R. analyzed data and wrote and edited the manuscript. All authors have
read and agreed to the published version of the manuscript.
Funding: The research was supported by the Natural Sciences and Engineering Research Council of Canada
awarded to S.J.R. The Canadian Institutes of Health Research and Ontario Early Researcher Awards provided
support for personnel (both awarded to S.J.R). M.J.J and G.J.B were supported by a Children’s Health Research
Institute Epigenetics fellowship. M.J.J. is supported by a fellowship from the Natural Sciences and Engineering
Research Council of Canada.
Acknowledgments: We would like to thank Janet Rossant (University of Toronto) for kindly providing F4 mouse
TS cells, and Seiji Ito (Kansai Medical University) for providing the Ovol2+/- mice. We also wish to thank Michele
Calder and Andrew Watson (University of Western Ontario) for their expertise and training on mouse breeding
and blastocyst collection, and Courtney Brooks (University of Western Ontario) for help in preparation of MEFs.
Conflicts of Interest: The authors declare no conflict of interest.

References
1.
2.
3.
4.
5.
6.

7.
8.

9.
10.

11.

12.

Baines, K.J.; Renaud, S.J. Transcription factors that regulate trophoblast development and function. Prog. Mol.
Biol. Transl. Sci. 2017, 145, 39–88.
Grigsby, P.L. Animal models to study placental development and function throughout normal and
dysfunctional human pregnancy. Semin. Reprod. Med. 2016, 34, 11–16. [CrossRef] [PubMed]
Woods, L.; Perez-Garcia, V.; Hemberger, M. Regulation of placental development and its impact on fetal
growth-new insights from mouse models. Front. Endocrinol. (Lausanne) 2018, 9, 570. [CrossRef] [PubMed]
Tanaka, S.; Kunath, T.; Hadjantonakis, A.K.; Nagy, A.; Rossant, J. Promotion of trophoblast stem cell
proliferation by FGF4. Science 1998, 282, 2072–2075. [CrossRef] [PubMed]
Okae, H.; Toh, H.; Sato, T.; Hiura, H.; Takahashi, S.; Shirane, K.; Kabayama, Y.; Suyama, M.; Sasaki, H.;
Arima, T. Derivation of human trophoblast stem cells. Cell Stem Cell 2018, 22, 50–63.e6. [CrossRef] [PubMed]
Perez-Garcia, V.; Fineberg, E.; Wilson, R.; Murray, A.; Mazzeo, C.I.; Tudor, C.; Sienerth, A.; White, J.K.;
Tuck, E.; Ryder, E.J.; et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants.
Nature 2018, 555, 463–468. [CrossRef] [PubMed]
Simmons, D.G.; Cross, J.C. Determinants of trophoblast lineage and cell subtype specification in the mouse
placenta. Dev. Biol. 2005, 284, 12–24. [CrossRef] [PubMed]
Douglas, G.C.; VandeVoort, C.A.; Kumar, P.; Chang, T.-C.; Golos, T.G. Trophoblast stem cells: Models for
investigating trophectoderm differentiation and placental development. Endocr. Rev. 2009, 30, 228–240.
[CrossRef]
Hemberger, M.; Hughes, M.; Cross, J.C. Trophoblast stem cells differentiate in vitro into invasive trophoblast
giant cells. Dev. Biol. 2004, 271, 362–371. [CrossRef]
Li, B.; Dai, Q.; Li, L.; Nair, M.; Mackay, D.R.; Dai, X. Ovol2, a mammalian homolog of Drosophila ovo:
Gene structure, chromosomal mapping, and aberrant expression in blind-sterile mice. Genomics 2002, 80,
319–325. [CrossRef]
Unezaki, S.; Nishizawa, M.; Okuda-Ashitaka, E.; Masu, Y.; Mukai, M.; Kobayashi, S.; Sawamoto, K.; Okano, H.;
Ito, S. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo,
as transcription factors. Gene 2004, 336, 47–58. [CrossRef] [PubMed]
Kumar, A.; Bhandari, A.; Sinha, R.; Sardar, P.; Sushma, M.; Goyal, P.; Goswami, C.; Grapputo, A.
Molecular phylogeny of OVOL genes illustrates a conserved C2H2 zinc finger domain coupled by
hypervariable unstructured regions. PLoS ONE 2012, 7, e39399. [CrossRef] [PubMed]

Cells 2020, 9, 840

13.

14.

15.
16.

17.

18.

19.

20.
21.

22.
23.
24.

25.

26.

27.

28.
29.

30.
31.

19 of 20

Ito, T.; Tsuji, G.; Ohno, F.; Nakahara, T.; Uchi, H.; Furue, M. Potential role of the OVOL1-OVOL2 axis and
c-Myc in the progression of cutaneous squamous cell carcinoma. Mod. Pathol. 2017, 30, 919–927. [CrossRef]
[PubMed]
Li, B.; Mackay, D.R.; Dai, Q.; Li, T.W.H.; Nair, M.; Fallahi, M.; Schonbaum, C.P.; Fantes, J.; Mahowald, A.P.;
Waterman, M.L.; et al. The LEF1/beta -catenin complex activates movo1, a mouse homolog of Drosophila ovo
required for epidermal appendage differentiation. Proc. Natl. Acad. Sci. USA 2002, 99, 6064–6069. [CrossRef]
[PubMed]
Taniguchi, H.; Katano, T.; Nishida, K.; Yao, I.; Morimoto, Y.; Matsuda, T.; Ito, S. Expression of hOvol2 in the
XY body of human spermatocytes. Andrologia 2017, 49, e12599. [CrossRef] [PubMed]
Watanabe, K.; Villarreal-Ponce, A.; Sun, P.; Salmans, M.L.; Fallahi, M.; Andersen, B.; Dai, X.
Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2
transcriptional repressor. Dev. Cell 2014, 29, 59–74. [CrossRef] [PubMed]
Teng, A.; Nair, M.; Wells, J.; Segre, J.A.; Dai, X. Strain-dependent perinatal lethality of Ovol1-deficient mice
and identification of Ovol2 as a downstream target of Ovol1 in skin epidermis. Biochim. Biophys. Acta 2007,
1772, 89–95. [CrossRef]
Unezaki, S.; Horai, R.; Sudo, K.; Iwakura, Y.; Ito, S. Ovol2/Movo, a homologue of Drosophila ovo, is
required for angiogenesis, heart formation and placental development in mice. Genes Cells 2007, 12, 773–785.
[CrossRef]
Renaud, S.J.; Chakraborty, D.; Mason, C.W.; Rumi, M.A.K.; Vivian, J.L.; Soares, M.J. OVO-like 1 regulates
progenitor cell fate in human trophoblast development. Proc. Natl. Acad. Sci. USA 2015, 112, E6175–E6184.
[CrossRef]
Quinn, J.; Kunath, T.; Rossant, J. Mouse Trophoblast stem cells. Methods Mol. Med. 2006, I, 125–148.
Zhu, D.; Gong, X.; Miao, L.; Fang, J.; Zhang, J. Efficient induction of Syncytiotrophoblast layer II cells from
Trophoblast stem cells by canonical Wnt signaling activation. Stem Cell Rep. 2017, 9, 2034–2049. [CrossRef]
[PubMed]
Jeyarajah, M.J.; Jaju Bhattad, G.; Kops, B.F.; Renaud, S.J. Syndecan-4 regulates extravillous trophoblast
migration by coordinating protein kinase C activation. Sci. Rep. 2019, 9, 10175. [CrossRef] [PubMed]
Schneider, C.A.; Rasband, W.S.; Eliceiri, K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods
2012, 9, 671–675. [CrossRef] [PubMed]
Wells, J.; Lee, B.; Cai, A.Q.; Karapetyan, A.; Lee, W.-J.; Rugg, E.; Sinha, S.; Nie, Q.; Dai, X. Ovol2 suppresses cell
cycling and terminal differentiation of keratinocytes by directly repressing c-Myc and Notch1. J. Biol. Chem.
2009, 284, 29125–29135. [CrossRef]
Ueno, M.; Lee, L.K.; Chhabra, A.; Kim, Y.J.; Sasidharan, R.; Van Handel, B.; Wang, Y.; Kamata, M.; Kamran, P.;
Sereti, K.-I.; et al. c-Met-dependent multipotent labyrinth trophoblast progenitors establish placental
exchange interface. Dev. Cell 2013, 27, 373–386. [CrossRef]
Zhu, D.; Hölz, S.; Metzger, E.; Pavlovic, M.; Jandausch, A.; Jilg, C.; Galgoczy, P.; Herz, C.; Moser, M.;
Metzger, D.; et al. Lysine-specific demethylase 1 regulates differentiation onset and migration of trophoblast
stem cells. Nat. Commun. 2014, 5, 3174. [CrossRef]
Roca, H.; Hernandez, J.; Weidner, S.; McEachin, R.C.; Fuller, D.; Sud, S.; Schumann, T.; Wilkinson, J.E.;
Zaslavsky, A.; Li, H.; et al. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial
transition in human cancer. PLoS ONE 2013, 8, e76773. [CrossRef] [PubMed]
Mackay, D.R.; Hu, M.; Li, B.; Rhéaume, C.; Dai, X. The mouse Ovol2 gene is required for cranial neural tube
development. Dev. Biol. 2006, 291, 38–52. [CrossRef]
Ye, G.-D.; Sun, G.-B.; Jiao, P.; Chen, C.; Liu, Q.-F.; Huang, X.-L.; Zhang, R.; Cai, W.-Y.; Li, S.-N.; Wu, J.-F.; et al.
OVOL2, an Inhibitor of WNT signaling, reduces invasive activities of human and mouse cancer cells and is
down-regulated in human colorectal tumors. Gastroenterology 2016, 150, 659–671.e16. [CrossRef] [PubMed]
Payre, F.; Vincent, A.; Carreno, S. Ovo/svb integrates Wingless and DER pathways to control epidermis
differentiation. Nature 1999, 400, 271–275. [CrossRef]
Hong, T.; Watanabe, K.; Ta, C.H.; Villarreal-Ponce, A.; Nie, Q.; Dai, X. An Ovol2-Zeb1 mutual inhibitory circuit
governs bidirectional and multi-step transition between epithelial and mesenchymal states. PLoS Comput.
Biol. 2015, 11, e1004569. [CrossRef] [PubMed]

Cells 2020, 9, 840

32.

33.

34.

35.

36.
37.

38.
39.

40.
41.

42.

43.

20 of 20

Bai, R.; Kusama, K.; Nakamura, K.; Sakurai, T.; Kimura, K.; Ideta, A.; Aoyagi, Y.; Imakawa, K. Down-regulation
of transcription factor OVOL2 contributes to epithelial-mesenchymal transition in a noninvasive type of
trophoblast implantation to the maternal endometrium. FASEB J. 2018, 32, 3371–3384. [CrossRef] [PubMed]
Wang, Z.-H.; Li, Z.; Hu, M.; Yang, Q.-J.; Yan, S.; Wu, R.-S.; Li, B.-A.; Guo, M. Ovol2 gene inhibits the
Epithelial-to-Mesenchymal Transition in lung adenocarcinoma by transcriptionally repressing Twist1. Gene
2017, 600, 1–8. [CrossRef]
Watanabe, K.; Liu, Y.; Noguchi, S.; Murray, M.; Chang, J.-C.; Kishima, M.; Nishimura, H.; Hashimoto, K.;
Minoda, A.; Suzuki, H. OVOL2 induces mesenchymal-to-epithelial transition in fibroblasts and enhances
cell-state reprogramming towards epithelial lineages. Sci. Rep. 2019, 9, 6490. [CrossRef] [PubMed]
Jones, J.M.; Montcouquiol, M.; Dabdoub, A.; Woods, C.; Kelley, M.W. Inhibitors of differentiation and DNA
binding (Ids) regulate Math1 and hair cell formation during the development of the organ of Corti. J. Neurosci.
2006, 26, 550–558. [CrossRef] [PubMed]
Roschger, C.; Cabrele, C. The Id-protein family in developmental and cancer-associated pathways.
Cell Commun. Signal. 2017, 15, 7. [CrossRef]
Li, B.; Nair, M.; Mackay, D.R.; Bilanchone, V.; Hu, M.; Fallahi, M.; Song, H.; Dai, Q.; Cohen, P.E.; Dai, X.
Ovol1 regulates meiotic pachytene progression during spermatogenesis by repressing Id2 expression.
Development 2005, 132, 1463–1473. [CrossRef]
Wang, L.-H.; Baker, N.E. Salvador-Warts-Hippo pathway in a developmental checkpoint monitoring
helix-loop-helix proteins. Dev. Cell 2015, 32, 191–202. [CrossRef]
Guo, G.; Huss, M.; Tong, G.Q.; Wang, C.; Li Sun, L.; Clarke, N.D.; Robson, P. Resolution of cell fate decisions
revealed by single-cell gene expression analysis from zygote to blastocyst. Dev. Cell 2010, 18, 675–685.
[CrossRef]
Selesniemi, K.; Albers, R.E.; Brown, T.L. Id2 mediates differentiation of labyrinthine placental progenitor cell
line, SM10. Stem Cells Dev. 2016, 25, 959–974. [CrossRef]
Janatpour, M.J.; McMaster, M.T.; Genbacev, O.; Zhou, Y.; Dong, J.; Cross, J.C.; Israel, M.A.; Fisher, S.J.
Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration. Development
2000, 127, 549–558. [PubMed]
Liu, Y.-P.; Burleigh, D.; Durning, M.; Hudson, L.; Chiu, I.-M.; Golos, T.G. Id2 is a primary partner for the E2-2
basic helix-loop-helix transcription factor in the human placenta. Mol. Cell. Endocrinol. 2004, 222, 83–91.
[CrossRef] [PubMed]
Townley-Tilson, W.H.D.; Wu, Y.; Ferguson, J.E.; Patterson, C. The ubiquitin ligase ASB4 promotes trophoblast
differentiation through the degradation of ID2. PLoS ONE 2014, 9, e89451. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).

